As 2014 draws to a close, the Winship Cancer Institute at Emory University is able to look back at a banner year, with record numbers of clinical trials, national recognitions for excellence and successful fundraising.
2014 has been an exciting year for Walter J. Curran, director of the Winship Cancer Institute, Emory University. Recently Curran sat down to answer five key questions about his work at Winship and the future of cancer research.
Since its founding in 1937, Winship Cancer Institute has offered outstanding cancer treatment and pursued cancer research. From 14,000 patients seen annually to 250 active clinical trials, the statistics are impressive.
Patients who have a biopsy or surgery connected to a breast cancer diagnosis and allow some of their left-over tissue to be used in Emory's breast tissue bank are helping researchers find answers to improving diagnosis, treatment, even prevention of breast cancer.
Winship Cancer Institute clinicians and scientists work with their research partners across campus and the country to design, develop, and test new, personalized treatment regimens. Increasingly those regimens are specific to each patient.
A video-based tool given to prostate cancer patients significantly improved their understanding of key terms essential to making decisions about prostate cancer treatment, according to a study initiated by the Winship Cancer Institute of Emory University and published today in Cancer, the peer-reviewed journal of the American Cancer Society.
Lily Yang, professor of surgery and radiology and the Nancy Panoz Chair of Surgery in cancer research, has focused her current research on developing multifunctional, tumor-targeting nanoparticles.
Since 2007, a whopping 75 percent of all new FDA-approved cancer drugs have been tested through a clinical trial at Winship Cancer Institute, Emory University. And that's thanks to thousands of patients stepping up to enroll in clinical trials and receive experimental treatment, advancing medicine for others.
John G. Pattaras, MD, FACS has introduced an organ-sparing kidney cancer surgery at Emory Saint Joseph's Hospital. This involves removing the tumor and reconstructing the patient's kidney through the advancement of robotics.
A team of 11 dedicated Emory Healthcare nurses participated in Atlanta's 3-Day 60 mile Susan G. Komen Walk, raising more than $26,000 for breast cancer research.Emory Healthcare nurses raised more than $26,000 for breast cancer research.